Clinical Trials Directory

Trials / Completed

CompletedNCT03775382

Mechanisms of Impaired Brain Blood Flow With Aging

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
University of Delaware · Academic / Other
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Accepted

Summary

Aging is the primary risk factor for Alzheimer's disease (AD), which is a rapidly growing public health concern. Understanding the mechanisms of normal brain aging may provide insight into the factors linking advancing age to increased risk for AD and thereby lead to new therapeutic targets for preventing or slowing AD progression. Cardiovascular changes, including impaired cerebrovascular function, occur with aging and may increase risk for AD; however, the mechanisms by which cerebrovascular function becomes impaired in older adults are incompletely understood. The overall goal of this project is to examine potential mechanisms of age-related declines in cerebrovascular function in humans. The investigators hypothesize that brain macro-vascular endothelial dysfunction, secondary to oxidative stress, plays an important role in mediating age-related changes in brain blood flow and cerebrovascular reactivity. The results of this pilot study have the potential to identify novel targets of cerebrovascular aging and will help guide the design of future clinical trials aimed at improving cerebral blood flow in older adults.

Conditions

Interventions

TypeNameDescription
OTHERAscorbic AcidAscorbic acid will be infused into an antecubital vein using a IV infusion pump beginning with a priming bolus of 0.06 g Ascorbic Acid per kg fat-free mass dissolved in 100 ml of saline followed by a "drip-infusion" of 0.02 g Ascorbic Acid per kg fat-free mass dissolved in 30 ml of saline.
OTHERNormal SalineNormal saline will be infused by the research nurse into an antecubital vein using an IV infusion pump.

Timeline

Start date
2017-10-30
Primary completion
2022-06-01
Completion
2022-06-01
First posted
2018-12-13
Last updated
2023-05-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03775382. Inclusion in this directory is not an endorsement.